N-(Pyrazin-2-ylcarbonyl)glycine
CAS: 57229-37-5
Ref. 3D-HCA22937
| 1g | Descatalogado | ||
| 5g | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado | ||
| 2500mg | Descatalogado |
Información del producto
Nombre:
N-(Pyrazin-2-ylcarbonyl)glycine
Sinónimos:
- Glycine, N-pyrazinoyl-
- N-(2-Pyrazinylcarbonyl)glycine
- Glycine, N-(2-pyrazinylcarbonyl)-
- Glycine, N-(pyrazinylcarbonyl)-
- Pyrazinoylglycine
Descripción:
N-(Pyrazin-2-ylcarbonyl)glycine (PZAG) is a prodrug that is converted to pyrazinoic acid in vivo. It is an inhibitor of HIV protease and has been shown to have a pharmacokinetic profile suitable for once-daily administration. PZAG has also been shown to inhibit the production of uric acid, which may be due to its ability to inhibit deamidases that produce uric acid from purines. PZAG may interact with other drugs, such as antibiotics, which are involved in the elimination phase of drug metabolism.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
181.15 g/mol
Fórmula:
C7H7N3O3
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
